A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. (GT1110791)

This study has been terminated.

(Study has now been terminated due to changes in project strategy. Current available data will be analysed and reported in a synoptic study report.)

Sponsor:

Information provided by:

GlaxoSmithKline

ClinicalTrials.gov Identifier:

NCT00929370

First received: June 25, 2009

Last updated: NA

Last verified: June 2009

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2009
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)